Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabis Oil for Cancer-Related Symptoms
NCT03948074Phase 2Completed
- Start
- Feb 2021
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dronabinol, cannabidiol in cancer pain, nausea ((none)), anxiety disorder, sleep disorder. Started Feb 2021; status: completed.
02
Drugs
dronabinolcannabidiol
03
Conditions
cancer painnausea ((none))anxiety disordersleep disorder
Beyond the preview
Go deeper on NCT03948074.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03948074.